Treatment-Associated Serum FSH Levels in Very Poor Responders to Ovarian Stimulation

Journal of Assisted Reproduction and Genetics

Volumn 20, Issue 10, 2003, Pages 395-399

  Saadat, Peyman ^a,b   Slater, Cristin C ^a   Jain, John K ^a   Tourgeman, David E ^a   Stanczyk, Frank Z ^a   Paulson, Richard J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

Clomiphene hMG; In vitro fertilization; Microdose flare; Poor responders

Indexed keywords

CLOMIPRAMINE; ESTRADIOL; ESTRONE SULFATE; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG POTENCY; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; OOCYTE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND; UTERUS;

ADULT; BODY MASS INDEX; CELL COUNT; CLOMIPHENE; ESTRADIOL; ESTRONE; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LEUPROLIDE; OOCYTES; OVULATION INDUCTION; RETROSPECTIVE STUDIES;

FALLOPIA;

EID: 0242595633     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026280508821     Document Type: Article

References (25)

1. Anserini P, Magnasco A, Remorgida V, Gaggero G, Testa D, Capitanio GL: Comparison of a blocking vs. flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test. Gynecol Endocrinol 1997;11:321-326
2. Muasher SJ: Treatment of low responders. J Assist Reprod Genet 1993;10:112-114
3. Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, Masson GM: Comparison of "poor" responders with "good" responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 1991;6:918-921
4. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 1987;2:645-647
5. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298-307
6. Dor J, Seidman DS, Ben-Shlomo I, Levran D, Karasik A, Mashiach S: The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J Assist Reprod Genet 1992;9:228-232
7. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L: Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93-97
8. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343-346
9. Karacan M, Erkan H, Karabulut O, Sarikamis B, Camlibel T, Benhabib M: Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a. J Reprod Med 2001;46:485-489
10. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL: High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-965
11. Paulson RJ, Marrs RP: Ovulation stimulation and monitoring for in-vitro fertilization. Curr Probl Obstet Gynecol Infert 1986;9:497-526
12. Diamond MP, Hill GA, Webster BW, Herbert CM, Rogers BJ, Osteen KG, Maxson WS, Vaughn WK, Wentz AC: Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization. Fertil Steril 1986;46:1108-1112
13. Tanbo T, Dale PO, Abyholm T, Stokke KT: Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization. Hum Reprod 1989;4:647-650
14. Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;61:880-885
15. Huisman GJ, Fauser BC, Eihkemans MJ, Pieters MH: Implantation rates after in vitro fertilization and transfer of maximum of two embryos that have undergone three to five days of culture. Fertil Steril 2000;73:117-122
16. Veeck LL: An Atlas of Human Gametes and Conceptuses. New York, Parthenon, 1998, pp 40-45
17. Scott RT, Jr, Hofmann GE, Oehninger S, Muasher SJ: Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302
18. Manzi DL, Thornton KL, Scott LB, Nulsen JC: The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response. Fertil Steril 1994;62:251-256
19. Surrey ES, Schoolcraft WB: Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667-676
20. Coulam C, Stanczyk FZ, Paulson RJ: Estrone sulfate as a predictor of gonadotropin response during controlled ovarian hyperstimulation (COH). Fertil Steril 1999;71(Suppl 1):9S
21. Surrey ES, Bower JA, Hill DM, Ramsey J, Surrey MW: Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419-424
22. Lessing JB, Peyser MR, Gilad S, Amit A, Kogosowski A, Yovel I, Barak Y, David MP: Estrone-3-glucuronide chemiluminescence immunoassay: An alternative method for monitoring induction of ovulation with human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril 1987;48:450-453
23. Rapi S, Fuzzi B, Mannelli M, Pratesi S, Criscuoli L, Pellegrini S, Messeri G: Estrone-3-glucuronide chemiluminescence immunoassay (LIA) and 17β-estradiol radioimmunoasay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): Correlation with follicular parameters and oocyte maturity. Acta Eur Fertil 1992;23:63-68
24. Diamond MP, Maxson WS, Vaughn WK, Osteen KG, Wentz AC: Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol. J In Vitro Fert Embryo Transf 1986;3:106-109
25. Maxson WS, Pittaway DE, Herbert CM, Garner CH, Wentz AC: Antiestrogenic effect of clomiphene citrate: Correlation with serum estradiol concentrations. Fertil Steril 1984;42:356-359